Skip to main content
. 2012 Jun;180(6):2240–2248. doi: 10.1016/j.ajpath.2012.03.008

Figure 1.

Figure 1

Deletion and amplification of segments of genomes in blood, AT, and prostate cancer samples. A: Histograms of genome deletion (blue) or amplification (red) of blood (B), AT, and tumor (T) in 23 pairs of human chromosomes. B: Box plot of number of genes overlapping with CNV per sample. Outliers in blood and AT samples are indicated. C: Venn diagram of deleted or amplified genes occurring in at least one sample overlapping between blood, AT, and tumor. D: The spectrum of genes that are amplified or deleted in blood, AT, and tumors that did not relapse (Tnone), tumors that relapsed and had a PSADT at or after 15 months of radical prostatectomy (Tslow), and tumors that relapsed and had a PSADT within 4 months of radical prostatectomy (Tfast).